What causes Duchenne muscular dystrophy?

Mutations in the dystrophin gene lead to the absence of, or defects in, dystrophin – an important component of the muscle cell membrane.1,2

Dystrophin is an important component of the muscle cell membrane1

Adapted from Marieb EN, et al. 20133 and MDA4

Dystrophin is present in all muscles, including skeletal, cardiac and respiratory muscle.2,4,5 Dystrophin is a structural protein that provides mechanical stability5–7

Dystrophin protein structure and interactions

Adapted from Goemans N, et al. 20141
  • Links internal cytoskeleton to sarcoglycans/dystroglycansin the membrane and the extracellular matrix5,6
  • Provides mechanical stability and structure to muscle cell membrane during contraction5–7
  • Critical to structure/stability of all muscles, including respiratory and cardiac muscles5

The absence of dystrophin leads to muscle degeneration and fibrosis11,12

Once muscle is lost it cannot be replaced.2,10,12 The absence of dystrophin in Duchenne muscular dystrophy results in ongoing muscle damage, and replacement of muscle fibres by scar tissue and fat12

Adapted from Sweeney HL. 201413
With permission from H Lee Sweeney, PhD, Myology Institute, University of Florida, FL, USA.

By the age of 5, prominent muscle weakness becomes evident with a 50–60% drop in strength14

By age 6, only 60% of predicted muscle mass is retained, decreasing to just 20% at age 1615

Early intervention is critical to help delay disease progression and treat potentially life-threatening complications.2,8–10

Click here to find out how you can help.

1. Goemans N, et al. Euro Neuro Rev. 2014;9(1):78–82.
2. Birnkrant DJ, et al. Lancet Neurol. 2018;17:251–267.
3. Marieb EN, Mitchell SJ. Human anatomy & physiology. 9th edition. Pearson; 2013.
4. Muscular Dystrophy Association. DMD muscular dystrophy (DMD): causes/inheritance. Available at: https://www.mda.org/disease/DMD-muscular-dystrophy/causes-inheritance [last accessed November 2020].
5. Nowak KJ, Davies KE. EMBO Rep. 2004;5(9):872–876.
6. Pichavant C, et al. Mol Ther. 2011;19(5):830–840.
7. Ervasti JM. Biochim Biophys Acta. 2007;1772(2):108–117.
8. van Ruiten HJ, et al. Arch Dis Child. 2014;99:1074–1077.
9. Lurio JG, et al. Am Fam Physician. 2015;91:38–44.
10. Laing NG, et al. Clin Biochem Rev. 2011;32:129–134.
11. Grounds MD, et al. Dis Model Mech. 2020;13(2):dmm043638.
12. Blake DJ, et al. Physiol Rev. 2002;82:291–329.
13. Sweeney HL. Developing skeletal muscle MRI/MRS as a biomarker for DMD therapeutic development. 2014 Annual Connect Conference, Chicago, IL, USA.
14. Mendell JR, Lloyd-Puryear M. Muscle Nerve. 2013;48:21–26.
15. Griffiths RD, Edwards RHT. Arch Dis Child. 1988;63:1256–1258.

Our Use of Cookies

In addition to cookies that are necessary to operate this website, we use optional cookies to provide website functionality and give you the best possible experience. We won't set optional cookies unless you enable them. For more detailed information see our Cookie Statement , which explains among others, how to set your cookie preferences and how to recall your consent.

Cookie Settings

Some cookies are essential, others help us improve your experience by providing insights into how the website is used. Select the cookie types listed below, and then save your preferences. Refer to our Cookie Statement for more information.

Strictly Necessary cookies
Strictly necessary cookies enable core functionality such as security, network management, and accessibility.

I accept the advertising/targeting cookies
Advertising/targeting cookies, which we use to track user activity and sessions so that we can deliver a more personalized service, and (in the case of advertising cookies) which are set by the third parties with whom we execute advertising campaigns and allow us to provide advertisements relevant to you.